Ranix Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Ranix has a total shareholder equity of ₩7.2B and total debt of ₩16.7B, which brings its debt-to-equity ratio to 230.8%. Its total assets and total liabilities are ₩26.2B and ₩18.9B respectively.

Belangrijke informatie

230.8%

Verhouding schuld/eigen vermogen

₩16.71b

Schuld

Rente dekkingsration/a
Contant₩5.87b
Aandelen₩7.24b
Totaal verplichtingen₩18.92b
Totaal activa₩26.16b

Recente financiële gezondheidsupdates

Recent updates

Here's Why Ranix (KOSDAQ:317120) Can Afford Some Debt

Jul 16
Here's Why Ranix (KOSDAQ:317120) Can Afford Some Debt

Ranix (KOSDAQ:317120) Is Making Moderate Use Of Debt

Mar 04
Ranix (KOSDAQ:317120) Is Making Moderate Use Of Debt

Ranix (KOSDAQ:317120) Is Carrying A Fair Bit Of Debt

Apr 14
Ranix (KOSDAQ:317120) Is Carrying A Fair Bit Of Debt

If You Had Bought Ranix (KOSDAQ:317120) Stock A Year Ago, You Could Pocket A 67% Gain Today

Feb 17
If You Had Bought Ranix (KOSDAQ:317120) Stock A Year Ago, You Could Pocket A 67% Gain Today

Ranix (KOSDAQ:317120) Is Carrying A Fair Bit Of Debt

Dec 24
Ranix (KOSDAQ:317120) Is Carrying A Fair Bit Of Debt

Analyse van de financiële positie

Kortlopende schulden: A317120's short term assets (₩8.8B) exceed its short term liabilities (₩6.2B).

Langlopende schulden: A317120's short term assets (₩8.8B) do not cover its long term liabilities (₩12.7B).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: A317120's net debt to equity ratio (149.7%) is considered high.

Schuld verminderen: Insufficient data to determine if A317120's debt to equity ratio has reduced over the past 5 years.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: A317120 has sufficient cash runway for more than a year based on its current free cash flow.

Voorspelling contante baan: A317120 has sufficient cash runway for 1.3 years if free cash flow continues to grow at historical rates of 10.1% each year.


Ontdek gezonde bedrijven